MedTrace Logo

Preliminary Effectiveness of Process-Based Personalized Physiotherapy for (Sub)Acute Neck Pain

NCT07704593 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 11

Last updated 2026-07-15

No results posted yet for this study

Summary

The goal of this clinical trial is to learn if personalized physiotherapy can lower neck pain in adults with recent (sub)acute neck pain who have a higher chance of the pain becoming long-lasting. The main questions it aims to answer are:

Does personalized physiotherapy lower pain compared to standard physiotherapy? Does personalized physiotherapy improve daily activities, quality of life, and pain interference compared to standard physiotherapy? Do physiotherapists deliver the personalized treatment as intended?

Researchers will compare each participant's own results during a standard care period to their results during a personalized care period, to see if the personalized approach works better than standard care.

Participants will:

Receive standard physiotherapy care for 3 weeks Then receive personalized physiotherapy, tailored to their individual needs, for several weeks (until their treatment goals are achieved) Answer short questions about their pain and daily functioning three times a week Take part in an interview about their experiences every 3 weeks

Conditions

  • Precision Medicine

Interventions

BEHAVIORAL

Personalized physiotherapy grounded in the PBT framework

During the intervention phase (B-phase), treatment follows the steps of personalized physiotherapy grounded in a PBT framework. Treatment is continuously adapted to the identified and prioritized modifiable biopsychosocial process, as jointly mapped and evaluated with the patient throughout the treatment trajectory. Intervention sequencing is not time-driven but process-driven, with session-by-session evaluation guiding when to continue, adapt, or shift intervention targets. The identification and ongoing evaluation of relevant processes is informed by the Clinical Compass and, where indicated, supplemented with one or more items from the supplementary item pool. Assessment is guided by a structured biopsychosocial evaluation using the SCEGS framework (Somatic, Cognitive, Emotional, Behavioral, Social), which supports systematic exploration of somatic symptoms, cognitions, emotions, behaviors, and social context to identify modifiable processes.

Sponsors & Collaborators

  • Maastricht University

    collaborator OTHER

  • University of Applied Sciences Utrecht

    lead OTHER

Principal Investigators

  • Sophie Konings, MSc · University of Applied Sciences Utrecht

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-08-01
Primary Completion
2027-07-31
Completion
2027-07-31

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07704593 on ClinicalTrials.gov